Scarica l'app Stockscreener
8.02
5.92%
-0.505
Dopo l'orario di chiusura:
8.50
0.48
+5.99%
Precedente Chiudi:
$8.525
Aprire:
$8.8134
Volume 24 ore:
21,881
Relative Volume:
0.47
Capitalizzazione di mercato:
$25.49M
Reddito:
-
Utile/perdita netta:
$-68.80M
Rapporto P/E:
-6.8547
EPS:
-1.17
Flusso di cassa netto:
$-59.06M
1 W Prestazione:
-7.66%
1M Prestazione:
+10.32%
6M Prestazione:
+2,338%
1 anno Prestazione:
+1,257%
Intervallo 1D:
$8.02
$8.92
Intervallo di 1 settimana:
$8.00
$9.00
Portata 52W:
$0.257
$9.00
Passage Bio Inc Stock (PASG) Company Profile
Nome
Passage Bio Inc
Settore
Industria
Telefono
(267) 866-0312
Indirizzo
ONE COMMERCE SQUARE, PHILADELPHIA, PA
Confronta PASG con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PASG
Passage Bio Inc
|
8.02 | 27.06M | 0 | -68.80M | -59.06M | -1.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Passage Bio Inc Stock (PASG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-29 | Ripresa | Wedbush | Outperform |
| 2024-09-03 | Iniziato | Rodman & Renshaw | Buy |
| 2022-03-08 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-01-19 | Downgrade | Goldman | Buy → Neutral |
| 2021-07-01 | Iniziato | Raymond James | Outperform |
| 2021-06-15 | Iniziato | BTIG Research | Buy |
| 2021-03-04 | Aggiornamento | Goldman | Neutral → Buy |
| 2021-02-04 | Iniziato | Guggenheim | Buy |
| 2021-01-25 | Iniziato | Wedbush | Outperform |
| 2021-01-04 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-12-11 | Iniziato | Citigroup | Neutral |
| 2020-08-14 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-06-25 | Downgrade | Goldman | Buy → Neutral |
| 2020-03-25 | Iniziato | Chardan Capital Markets | Buy |
| 2020-03-24 | Iniziato | Cowen | Outperform |
| 2020-03-24 | Iniziato | Goldman | Buy |
| 2020-03-24 | Iniziato | JP Morgan | Overweight |
Mostra tutto
Passage Bio Inc Borsa (PASG) Ultime notizie
Passage Bio Inc Stock Analysis and ForecastMarket Depth Overview & Capitalize On Fast Trends - earlytimes.in
What’s next for Passage Bio Inc. stock price2025 Major Catalysts & Real-Time Sentiment Analysis - newser.com
Why Passage Bio Inc. stock could rally in 2025July 2025 Reactions & Fast Exit/Entry Strategy Plans - newser.com
What analysts say about Passage Bio Inc stockEarnings Beat Highlights & Exceptional Growth Portfolio - earlytimes.in
Predicting Passage Bio Inc. trend using moving averages2025 Price Targets & Free Long-Term Investment Growth Plans - newser.com
Using flow based indicators on Passage Bio Inc.Earnings Risk Report & AI Enhanced Trading Alerts - newser.com
Key resistance and support levels for Passage Bio Inc.July 2025 Closing Moves & Safe Entry Zone Tips - newser.com
Multi asset correlation models including Passage Bio Inc.Market Volume Summary & Real-Time Volume Triggers - newser.com
Passage Bio Inc. stock prediction for this week2025 Pullback Review & Pattern Based Trade Signal System - newser.com
Passage Bio to Participate in Chardan’s 9th Annual Genetic Medicines Conference - The Manila Times
Smart tools for monitoring Passage Bio Inc.’s price actionPortfolio Growth Summary & Weekly Chart Analysis and Trade Guides - newser.com
Published on: 2025-10-14 01:59:31 - newser.com
What the charts say about Passage Bio Inc. today2025 Geopolitical Influence & Reliable Volume Spike Alerts - newser.com
Passage Bio CFO sells shares worth $1,685 - MSN
How to build a custom watchlist for Passage Bio Inc.July 2025 Drop Watch & Free Weekly Watchlist of Top Performers - newser.com
Full technical analysis of Passage Bio Inc. stockWeekly Profit Analysis & Real-Time Chart Pattern Alerts - newser.com
Passage Bio Inc. stock daily chart insightsTake Profit & Weekly Watchlist of Top Performers - newser.com
How buybacks impact Passage Bio Inc. stock valueTrade Risk Report & AI Driven Stock Reports - newser.com
Is it too late to sell Passage Bio Inc.Bull Run & Weekly High Momentum Picks - newser.com
Is Passage Bio Inc. stock poised for growthWeekly Risk Report & Safe Capital Preservation Plans - newser.com
Is Passage Bio Inc. reversing from oversold territory2025 Pullback Review & High Accuracy Trade Signal Alerts - newser.com
Passage Bio (NASDAQ:PASG) Trading Up 1.8% – Time to Buy? - Defense World
Passage Bio Inc Azioni (PASG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Passage Bio Inc Azioni (PASG) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 10% Owner |
Sep 15 '25 |
Buy |
6.99 |
11,900 |
83,175 |
623,704 |
| Lynx1 Capital Management LP | 10% Owner |
Sep 11 '25 |
Buy |
6.96 |
325 |
2,261 |
592,021 |
| Lynx1 Capital Management LP | 10% Owner |
Jul 24 '25 |
Buy |
5.71 |
66,423 |
379,455 |
591,696 |
| Lynx1 Capital Management LP | 10% Owner |
Jul 23 '25 |
Buy |
5.74 |
49,302 |
283,033 |
525,273 |
| Lynx1 Capital Management LP | 10% Owner |
Jul 22 '25 |
Buy |
5.44 |
13,123 |
71,338 |
475,971 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):